Budesonide is not beneficial for the treatment of diarrhea in metastatic melanoma patients

PHILADELPHIA -- Patients with stage III or IV melanoma taking ipilimumab and the oral steroid budesonide to reduce side effects did not have less diarrhea, a known side effect of ipilimumab, according to results of a phase II trial published in Clinical Cancer Research, a journal of the American Association for Cancer Research.

Read the whole article on Science Blog

More from Science Blog